Choroba Castlemana – opis przypadku
Journal Title: Otolaryngologia Polska - Year 2008, Vol 62, Issue 5
Abstract
The Castleman disease was described for the first time in 1956 by Castleman. It is a rare disease of the lymphatic tissue, manifesting in excessive proliferation of lymphocites B and plasmatic cells in lymph nodes. The etiopathogenesis if the disease still is unknown. The paper presents a case of the Castlemana disease (hyaline vascular type) in 20-year old man with unilateral enlargement of neck lymph nodes. The case exemplifies the difficulties met in diagnostics and treatment of the Castleman disease.
Authors and Affiliations
Dariusz Kaczmarczyk, Joanna Zimmer-Nowicka, Dorota Jesionek-Kupnicka, Izabela Niedźwiecka, Aleksandra Golińska, Alina Morawiec-Sztandera
Keywords
Related Articles
- EP ID EP51624
- DOI -
- Views 120
- Downloads 0
The influence of the systemic glucocorticosteroid therapy and intranasal surgery on the taste and smell senses in patients with nasal polyps
Evaluation of apoptosis expression in granulation tissue in chronic otitis media
Introduction: There is a growing evidence that molecular and cellular mechanisms may play a role in pathogenesis in chronic otitis media. The aim of the study: was to determine the intensity of apoptosis in granulation t...
Diagnosis and treatment preauricular fistulas in children
SUMMARY Introduction: Preauricular fistulas are not uncommon congenital disorders in children. They are associated with imperfect auricle formation as a conse-quence of incomplete fusion of the auditory hillocks of the f...
Usefulness of 18F-FDG PET/CT examination in the diagnosis of head and neck cancer
SUMMARY Objectives: The aim of the study was to determine the usefulness of 18F-FDG PET/CT in oncological diagnostics in laryngology. Material and methods: 45 PET/CT examinations were performed in 41 pa-tients diagnosed...
Bakterioterapia w zapobieganiu nawracającym infekcjom górnych dróg oddechowych u dzieci: opisy rzeczywistych przypadków
Tło Nawracające infekcje górnych dróg oddechowych (NZDO) stanowią problem społeczny zarówno ze względu na swój wpływ farmakoterapeutyczny, jak i wpływ wywierany na życie rodzinne. W tym przypadku bakterioterapia może być...